SLAMF1-derived peptide exhibits cardio protection after permanent left anterior descending artery ligation in mice

Maria Belland Olsen, Xiang Yi Kong,Mieke C. Louwe, Knut H. Lauritzen, Ylva Schanke,Ole Jorgen Kaasboll, Havard Attramadal,Jonas Ogaard, Sverre Holm,Pal Aukrust,Liv Ryan, Terje Espevik,Maria Yurchenko,Bente Halvorsen

FRONTIERS IN IMMUNOLOGY(2024)

引用 0|浏览4
暂无评分
摘要
Acute myocardial infarction (MI) results in tissue damage to affected areas of the myocardium. The initial inflammatory response is the most damaging for residual cardiac function, while at later stages inflammation is a prerequisite for proper healing and scar formation. Balancing the extent and duration of inflammation during various stages after MI is thus pivotal for preserving cardiac function. Recently, a signaling lymphocytic activation molecule 1 (SLAMF1)-derived peptide (P7) was shown to reduce the secretion of inflammatory cytokines and protected against acute lipopolysaccharide-induced death in mice. In the present study, we experimentally induced MI by permanent ligation of the left anterior descending artery (LAD) in mice and explored the beneficial effect of immediately administering P7, with the aim of dampening the initial inflammatory phase without compromising the healing and remodeling phase. Blood samples taken 9 h post-LAD surgery and P7 administration dampened the secretion of inflammatory cytokines, but this dampening effect of P7 was diminished after 3 days. Echocardiography revealed less deterioration of cardiac contraction in mice receiving P7. In line with this, less myocardial damage was observed histologically in P7-treated mice. In conclusion, the administration of a SLAMF1-derived peptide (P7) immediately after induction of MI reduces the initial myocardial inflammation, reduces infarct expansion, and leads to less deterioration of cardiac contraction.
更多
查看译文
关键词
myocardial infarction,inflammation,TLR4,SLAMF1,P7
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要